AC
IRWD icon

AXQ Capital’s Ironwood Pharmaceuticals IRWD Stock Holding History

AXQ Capital’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$198K Buy
47,028
+34,079
+263% +$131K 0.02% 728
2026
Q1 		$45.5K Buy
+12,949
New +$53.1K 0.01% 935
2024
Q4 		– Sell
-14,929
Closed -$61.5K – 535
2024
Q3 		$61.5K Buy
+14,929
New +$80.3K 0.02% 410
2024
Q1 		– Sell
-23,100
Closed -$264K – 761
2023
Q4 		$264K Buy
23,100
+3,100
+16% +$30.7K 0.07% 419
2023
Q3 		$193K Buy
+20,000
New +$196K 0.07% 393

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AXQ Capital's IRWD Position: Q2 2026 in Review

AXQ Capital increased its Ironwood Pharmaceuticals (IRWD) stake by 263% in Q2 2026, buying an estimated $131K and bringing the position to 47,028 shares worth $198K. The position accounts for 0.02% of the portfolio, ranked #728.

AXQ Capital first reported a position in IRWD in Q3 2023 and has held it in 5 quarters since. The position peaked at $264K in Q4 2023. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • AXQ Capital held 47,028 shares of Ironwood Pharmaceuticals worth $198K as of Q2 2026.
  • AXQ Capital bought 34,079 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $131K.
  • Ironwood Pharmaceuticals made up 0.02% of AXQ Capital's portfolio in Q2 2026, its #728 holding.
  • AXQ Capital first reported a position in Ironwood Pharmaceuticals in Q3 2023 and has held it in 5 quarters since.
  • AXQ Capital's Ironwood Pharmaceuticals position peaked at $264K in Q4 2023.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.